DAFNA Capital Management as of March 31, 2018
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 75 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Loxo Oncology | 10.2 | $21M | 182k | 115.37 | |
Sage Therapeutics (SAGE) | 7.4 | $15M | 94k | 161.07 | |
Stereotaxis (STXS) | 4.4 | $9.0M | 14M | 0.66 | |
Blueprint Medicines (BPMC) | 4.0 | $8.1M | 89k | 91.70 | |
AtriCure (ATRC) | 3.9 | $8.0M | 389k | 20.52 | |
NxStage Medical | 3.7 | $7.6M | 306k | 24.86 | |
Aerie Pharmaceuticals | 3.5 | $7.2M | 133k | 54.25 | |
Akebia Therapeutics (AKBA) | 2.8 | $5.8M | 611k | 9.53 | |
Dex (DXCM) | 2.7 | $5.6M | 75k | 74.16 | |
Ascendis Pharma A S (ASND) | 2.5 | $5.2M | 79k | 65.40 | |
Alder Biopharmaceuticals | 2.5 | $5.0M | 396k | 12.70 | |
Arena Pharmaceuticals | 2.4 | $5.0M | 127k | 39.50 | |
Luminex Corporation | 2.3 | $4.8M | 228k | 21.07 | |
Argenx Se (ARGX) | 2.3 | $4.7M | 58k | 80.44 | |
BioCryst Pharmaceuticals (BCRX) | 2.3 | $4.6M | 975k | 4.77 | |
Neurocrine Biosciences (NBIX) | 2.2 | $4.5M | 55k | 82.92 | |
Cymabay Therapeutics | 2.0 | $4.2M | 324k | 12.99 | |
Immunomedics | 2.0 | $4.1M | 281k | 14.61 | |
Radius Health Inc note 3.000% 9/0 | 1.9 | $4.0M | 4.0M | 1.00 | |
Galapagos Nv- (GLPG) | 1.9 | $4.0M | 40k | 99.75 | |
Zogenix | 1.8 | $3.8M | 94k | 40.05 | |
Vbi Vaccines | 1.7 | $3.5M | 998k | 3.50 | |
Achillion Pharmaceuticals | 1.6 | $3.2M | 868k | 3.71 | |
Rigel Pharmaceuticals (RIGL) | 1.6 | $3.2M | 902k | 3.54 | |
Insulet Corporation (PODD) | 1.4 | $2.8M | 33k | 86.69 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.4 | $2.8M | 26k | 106.74 | |
Kura Oncology (KURA) | 1.2 | $2.4M | 127k | 18.75 | |
Scynexis | 1.1 | $2.2M | 1.6M | 1.34 | |
Biotelemetry | 1.1 | $2.2M | 70k | 31.05 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.0 | $2.1M | 2.5M | 0.85 | |
Macrogenics (MGNX) | 1.0 | $2.1M | 83k | 25.16 | |
Xenon Pharmaceuticals (XENE) | 0.9 | $1.9M | 378k | 4.90 | |
Wave Life Sciences (WVE) | 0.9 | $1.8M | 44k | 40.09 | |
Foamix Pharmaceuticals | 0.8 | $1.7M | 336k | 5.13 | |
Insulet Corp note 1.375% | 0.8 | $1.7M | 1.5M | 1.14 | |
Leap Therapeutics | 0.8 | $1.7M | 200k | 8.30 | |
Applied Genetic Technol Corp C | 0.8 | $1.6M | 421k | 3.85 | |
Clementia | 0.8 | $1.6M | 105k | 15.15 | |
Aquinox Pharmaceuticals | 0.7 | $1.5M | 108k | 14.08 | |
ArQule | 0.7 | $1.4M | 485k | 2.88 | |
Natus Medical | 0.6 | $1.3M | 38k | 33.64 | |
Proteostasis Therapeutics In | 0.6 | $1.3M | 267k | 4.75 | |
Incyte Corporation (INCY) | 0.6 | $1.2M | 15k | 83.33 | |
Ardelyx (ARDX) | 0.6 | $1.3M | 248k | 5.05 | |
Beigene (BGNE) | 0.6 | $1.2M | 7.3k | 167.94 | |
Johnson & Johnson (JNJ) | 0.6 | $1.2M | 9.4k | 128.19 | |
Cogentix Medical | 0.6 | $1.2M | 310k | 3.85 | |
Dermira Inc note 3.000% 5/1 | 0.6 | $1.2M | 1.5M | 0.79 | |
Advaxis | 0.6 | $1.2M | 697k | 1.69 | |
Cara Therapeutics (CARA) | 0.6 | $1.2M | 94k | 12.38 | |
Immune Design | 0.5 | $1.1M | 329k | 3.30 | |
Minerva Neurosciences | 0.5 | $1.1M | 171k | 6.25 | |
Sunesis Pharmaceuticals Inc Ne | 0.5 | $1.0M | 374k | 2.72 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.3 | $711k | 231k | 3.08 | |
Scpharmaceuticals (SCPH) | 0.3 | $692k | 56k | 12.39 | |
Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.3 | $676k | 573k | 1.18 | |
Gemphire Therapeutics | 0.3 | $651k | 100k | 6.51 | |
Dermira | 0.3 | $607k | 76k | 7.99 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.3 | $576k | 600k | 0.96 | |
BioTime | 0.2 | $489k | 182k | 2.69 | |
Masimo Corporation (MASI) | 0.2 | $440k | 5.0k | 88.00 | |
Spero Therapeutics (SPRO) | 0.2 | $421k | 30k | 14.25 | |
Sol Gel Technologies (SLGL) | 0.2 | $361k | 35k | 10.31 | |
Tandem Diabetes Care (TNDM) | 0.1 | $298k | 60k | 4.97 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.1 | $255k | 250k | 1.02 | |
Neos Therapeutics | 0.1 | $228k | 28k | 8.29 | |
Urogen Pharma (URGN) | 0.1 | $224k | 4.5k | 49.78 | |
Alder Biopharmaceuticals Inc convertible security | 0.1 | $228k | 250k | 0.91 | |
Sierra Oncology | 0.1 | $166k | 80k | 2.08 | |
Arcus Biosciences Incorporated (RCUS) | 0.1 | $116k | 7.5k | 15.47 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.1 | $93k | 23k | 4.02 | |
Obseva Sa | 0.0 | $92k | 6.8k | 13.56 | |
Unum Therapeutics Ord | 0.0 | $88k | 7.9k | 11.14 | |
Clearside Biomedical (CLSD) | 0.0 | $54k | 5.0k | 10.80 | |
Biondvax Pharmaceuticals Ltd spond ads | 0.0 | $18k | 3.4k | 5.30 |